Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma
2020-07-04
عنوان الدراسة
Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma
داعم الدراسة
Roche
دواء الدراسة
Bevacizumab
رقم بروتوكول الدراسة
MO22923
حالة الدراسة
Completed
موقع الدراسة
King Fahad Medical City (Riyadh)_ King Fahad Specialist Hospital (Dammam)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。